06 | ӿ | TopicSem | ||
11 | ӿ | Mono- and biallelic variant effects on disease at biobank scale | J.Club |
02 | ӿ | Analysis of metastatic potential by somatic mutations in cancer cell | TopicSem |
08 | ӿ | TopicSem | ||
17 | ӿ | Genetic risk factors have a substantial impact on healthy life years | J.Club |
05 | ӿ | Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage Response | J.Club |
31 | ӿ | Identifying Gene combination affecting Cancer patients’ Survival | TopicSem |
01 | ӿ | Association between IRF2BP1-rs60158447 and incidence of post ERCP pancreatitis. | TopicSem | |
29 | ӿ | Identifying candidate variants of PEP in merged dataset with new PSM control | TopicSem |
27 | ӿ | Improved pathogenicity prediction for rare human missense variants | J.Club |
23 | ӿ | Analysis of validation samples of Post-ERCP pancreatitis | TopicSem |
14 | ӿ | MSK-MET, a cohort of over 25,000 patients with metastasis across 50 cancer types. | MAInfo | |
25 | ӿ | Genetic variants associated with post-ERCP pancreatitis (PEP) | TopicSem |
10 | ӿ | . | TopicSem | |
19 | ӿ | The Cancer Surfaceome Atlas integrates genomic, functional and drug response data to identify actionable targets | J.Club |
06 | ӿ | TopicSem |
04 | ӿ | Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology | J.Club | |
13 | ӿ | TopicSem |
22 | ӿ | Polymorphism affecting Tacrolimus flat peak | TopicSem |
02 | ӿ | Rare variant contribution to human disease in 281,104 UK Biobank exomes | J.Club | |
07 | ӿ | Cancer register in UKB | MAInfo | |
14 | ӿ | Case reconstruction by candidate variants for PEP patients | TopicSem |
06 | ӿ | Polymorphism affecting Tacrolimus flat peak | TopicSem |
28 | ӿ | WES analysis of post-ERCP pancreatitis patients | TopicSem |
03 | ӿ | Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid Cancers | J.Club | |
12 | ӿ | WES analysis of post-ERCP pancreatitis patients | TopicSem | |
15 | ӿ | MSI analysis in Cancer. | MAInfo |
15 | ӿ | WES analysis of post-ERCP pancreatitis patients | TopicSem | |
23 | ӿ | Synthetic Cancer Survival | Seminar |
22 | ӿ | WES analysis of post-ERCP pancreatitis patients | TopicSem | |
25 | ӿ | metmap | MAInfo |
21 | ӿ | Synthetic Association with ERCC6-rs2228528in Pancreatic Cancer | TopicSem | |
24 | ӿ | Comparison deleteriousness between germline and somatic variants in cancer | MAInfo |
12 | ӿ | Identifying genetic variants that affect pancreatic cancer patients survival | TopicSem | |
29 | ӿ | Summary of Pancreatic cancer data analysis | MAInfo |
13 | ӿ | Pancreatic Cancer with New-onset Diabetes Mellitus | TopicSem | |
13 | ӿ | Affecting FOLFIRINOX sensitivity(CAP grade) variants | MAInfo |
09 | ӿ | A reference map of the human binary protein interactome | J.Club | |
14 | ӿ | Progression of tacrolimus study | MAInfo | |
18 | ӿ | Cpeak/C0 as indicator in follow-up of patients received transplant | TopicSem |
09 | ӿ | Comparison variants between TSVC and GATK pipeline | MAInfo | |
20 | ӿ | Pancreatic cancer sample with FNA WXS Analysis | TopicSem |
05 | ӿ | Pan-Cancer Analysis of Whole Genomes (PCAWG) project. | MAInfo | |
14 | ӿ | Identification of cancer driver genes based on nucleotide context | J.Club | |
26 | ӿ | Variant analysis in tacrolimus PK genes | TopicSem |
27 | ӿ | Identification of genomic markers affecting sentivity of tacrolimus | TopicSem |
09 | ӿ | Genetic polymorphism influences the pharmacokinetics of tacrolimus | TopicSem |
04 | ӿ | tacrolimus sensitivity analysis with clinical variables | TopicSem | |
09 | ӿ | Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype | J.Club |
21 | ӿ | Identification of genomic markers affecting sentivity of tacrolimus | Seminar |
05 | ӿ | Networks of Cancer Gene 6.0 | MAInfo | |
26 | ӿ | Tacrolimus high peaks variant analysis | TopicSem |
03 | ӿ | RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues | J.Club | |
12 | ӿ | FNA 3° м | TopicSem |
04 | ӿ | National Omics Data Encyclopedia (NODE) review | MAInfo | |
08 | ӿ | Tacrolimus sample sequencing summary | TopicSem |
09 | ӿ | Cancer Dependency Map | MAInfo | |
25 | ӿ | Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens | J.Club | |
30 | ӿ | SCS in public cellline data | TopicSem |
25 | ӿ | somatic mutation filtering in tumor-only sequencing data | TopicSem |
18 | ӿ | Pancreatic cancer FNA 2° sample м | TopicSem | |
21 | ӿ | Installation and Run of Neopepsee | MAInfo | |
23 | ӿ | Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer | J.Club |
03 | ӿ | HCMDB data curation | MAInfo | |
19 | ӿ | A map of constrained coding regions in the human genome | J.Club | |
31 | ӿ | Distribution of population frequency and SIFT/Gene Score in in SCS genes | TopicSem |
24 | ӿ | Relation between SCS and metastasis | TopicSem | |
26 | ӿ | Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden in Lung Adenocarcinoma | Seminar |
03 | ӿ | Network Propagation Predicts Drug Synergy in Cancers | J.Club | |
22 | ӿ | Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden in Lung Adenocarcinoma | TopicSem |
11 | ӿ | Variants calling workflow with GATK4 | MAInfo | |
25 | ӿ | Identification of SCS pairs in public pancreatic cancer data | TopicSem |
08 | ӿ | Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer | J.Club | |
13 | ӿ | Features associated immune checkpoint inhibitor | TopicSem |
06 | ӿ | SCS analysis in Pancreatic cancer | TopicSem |
05 | ӿ | Characteristics of germline SCS pair | TopicSem | |
07 | ӿ | Systematic analysis of complex genetic interactions | J.Club |
07 | ӿ | TMB and Tumor immune in SCS | TopicSem | |
18 | ӿ | pVACseq:A cancer immunotherapy pipeline for identifying and prioritizing neoantigens from a list of tumor mutations | MAInfo |
05 | ӿ | Drug sensitivity and SCS | TopicSem | |
08 | ӿ | OT & CTRP(Cancer Therapeutics Response Portal) review | MAInfo |
06 | ӿ | Re-analysis of SCS in colon cancer | TopicSem | |
14 | ӿ | Project DRIVE: deep RNAi interrogation of viability effects in cancer | xMutant | |
27 | ӿ | Network of Cancer genes 5.0 | MAInfo |
16 | ӿ | SCS analysis in Colon cancer cell lines | TopicSem |
12 | ӿ | Synthetic Cancer Survival relationship between DNA methylation and mutation | TopicSem |
29 | ӿ | Reassessment of Genomic Sequence Variation to Harmonize Interpretation for Personalized Medicine | J.Club |
27 | ӿ | TCGA never smoker LUAD mutation profile | TopicSem |
08 | ӿ | SMC lung cancer data analysis result | TopicSem | |
18 | ӿ | Somatic Mutation Patterns in Hemizygous Genomic Regions Unveil Purifying Selection during Tumor Evolution | J.Club |
02 | ӿ | Analysis plan of SMC lung cancer data. | TopicSem | |
25 | ӿ | Influence of Co-occurring Mutations on Clinical Outcomes in leukemia | MAInfo | |
25 | ӿ | SMC lung cancer data м | xMutant |
05 | ӿ | Pembrolizumab MSKCC data analysis | MAInfo | |
05 | ӿ | LUAD acs-mutation/expression analysis | xMutant | |
19 | ӿ | Differential characteristics among SCS burden groups | TopicSem |
03 | ӿ | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy | J.Club |
18 | ӿ | Identification SCS in COAD | TopicSem |
09 | ӿ | Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden | TopicSem |
11 | ӿ | Microsatellite instability in colorectal cancer—the stable evidence | MAInfo | |
23 | ӿ | Identification prognosis of patients with MSI in COAD | TopicSem |
14 | ӿ | Identification of Synthetic Cancer Survival and Synthetic Cancer Survival Burden in Multiple Cancer | TopicSem |
30 | ӿ | Lung cancer cell line sequence analysis | TopicSem |
06 | ӿ | Identification of Synthetic Survival and Synthetic Survival burden in multiple Cancer | TopicSem |
03 | ӿ | Patient survival trends of synthetic survival burden | TopicSem |
06 | ӿ | Identification of synthetic survival genes with survival analysis | TopicSem | |
16 | ӿ | Assessing the clinical utility of cancer genomic and proteomic data across tumor types | J.Club |
04 | ӿ | Cox regression with Penalized likelihood | xMutant |
16 | ӿ | Identification of potential synthetic lethal gene pairs. | TopicSem |
17 | ӿ | Identificiation of potential synthetic lethal genes with survival analysis | TopicSem | |
19 | ӿ | SKCM analysis result | xMutant |
06 | ӿ | Identifying potential synthetic lethal genes | TopicSem | |
10 | ӿ | ICGC LUSC Data analysis | xMutant | |
27 | ӿ | Identificiation of potential synthetic lethal genes with survival analysis | TopicSem |
04 | ӿ | Identification of potential synthetic lethals gene using mutation and clinical data in TCGA | TopicSem | |
14 | ӿ | Overview of Gene Ontology and its application | xMutant |
14 | ӿ | Identification of potential synthetic lethal genes in 12 tumor types | TopicSem | |
26 | ӿ | Identification of synthetic lethal pairs in biological systems through network information centrality | J.Club |
06 | ӿ | Identification of synthetic lethal genes in 12 major cancer types | xMutant | |
19 | ӿ | Identification potential synthetic lethal genes in cancer / CADD review | TopicSem |
22 | ӿ | Synthetic Lethality Analysis in TCGA BRCA somatic mutation data | TopicSem |
26 | ӿ | Synthetic Lethality Analysis of BRCA | xMutant |
03 | ӿ | Available public genomes for preprocessing: SIFT/PP2 Score | xMutant | |
04 | ӿ | SNPChase: correcting errors from diverse literatures and SNV databases | TopicSem | |
17 | ӿ | TCGA germline data labeling | xMutant |
22 | ӿ | DNMT3A in OMIM | MAInfo | |
31 | ӿ | J.Club |
10 | ӿ | SNPChase: correcting errors from diverse SNV databases for SNVs | TopicSem |